600272 | Human LDL-PLA2 Quimigen Portugal

Recombinant Protein

Cat. No.

600272

Unit

0.01 mg

Description

LP-PLA2 is an enzyme produced by inflammatory cells and hydrolyzes oxidised phospholipids in low-density lipoprotein (LDL). LP-PLA2 travels in the blood mainly with LDL and less than 20% is associated with high-density lipoprotein. LP-PLA2 is involved in the development of atherosclerosis and is a marker for cardiac disease. Recombinant LP-PLA2 comprises a 420 amino acid fragment (22-441) corresponding to the mature LP-PLA2 protein and is expressed in E. coli with an amino-terminal hexahistidine tag.

Spec Container

Datasheet

Format

Each vial contains 0.01 mg protein (liquid) in PBS pH7.4, 50% glycerol. Final concentration 0.1-1 mg/ml.

Alternate Names

LDL-PLA(2); Platelet-activating factor acetylhydrolase; PAF acetylhydrolase; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; Group-VIIA phospholipase A2; gVIIA-PLA2; LDL-associated phospholipase A2; LDL-PLA(2); PAF 2-acylhydrolase

Accession No.

Q13093

52.25 kDa

Sequence

His-Tag sequence not included: FDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNG PYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFL GTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYS AIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQ EEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDS IDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIP QPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFAT GKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEG DDENLIPGTNINTTNQHIMLQNSSGIEKYN

Source

E. coli

Purity

Purity > 95% as determined by reducing and non-reducing SDS-PAGE, Bradford assay, Western blot and ELISA.

Storage

Store at -20°C. Product is guaranteed one year from the date of shipment.

Images

For research use only, not for diagnostic or therapeutic procedures.

Human LDL-PLA2

Cat# 600272

Contact local distributor :

Brand : Abbiotec

Contact local distributor :

Spec Container